Pinsent Masons advises UK Government on first purchase of Covid-19 antivirals

21 Oct 2021 | 02:18 pm |

Multinational law firm Pinsent Masons has advised the UK government on its contracts for the purchase of significant volumes of two novel, Covid-19 specific, antivirals.

The two antivirals have been developed by MSD and Pfizer. MSD’s antiviral - Molnupiravir - has been shown to cut hospitalisation rates of Covid-19 patients by nearly half. It is also the first oral treatment that has been effective in treating Covid-19. The treatment works by targeting an enzyme the virus uses to make copies of itself. The Pfizer antiviral is in late-stage clinical development.

Commenting on the deal, lead life sciences partner Allistair Booth said:

"The response of the life sciences sector to the Covid-19 pandemic and what the sector has achieved is nothing short of phenomenal. The development of these antivirals is a further example of that. These drugs could play a key role in reducing hospitalisation of Covid-19 patients in the UK, helping to alleviate pressure on the NHS. We are proud to have worked with the UK government on securing these agreements.”

Alongside Allistair, the team working on the deals included life sciences experts Mario Subramaniam, Niki Ruprai, Andrew Cornforth, Kiah York, Serena Hitchcock, Ioana Chiva and Jackie Harris.

This follows the team’s work advising the UK government on its initial procurement of the Pfizer BioNTech Covid-19 vaccine and for its autumn revaccination programme.

Latest press releases

Show me all press releases

Pinsent Masons announces new co-heads of Madrid, Inmaculada Castelló and Fernando Gutiérrez

Multinational law firm Pinsent Masons has appointed Inmaculada Castelló and Fernando Gutiérrez as co-heads of the Madrid office as of 1 September 2022.

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons advises climate-tech venture capital fund, Systemiq Capital, on the $70m closing of its second fund

Multinational law firm Pinsent Masons has advised climate-tech VC fund Systemiq Capital on the $70 million first close of its second fund, targeting $200 million to continue backing the best early-stage climate tech entrepreneurs.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons wins Best Talent and Inclusion Initiative at The Lawyer Awards

Multinational law firm Pinsent Masons has won the Best Talent and Inclusion category at this year’s The Lawyer Awards.

Multiple wins for Pinsent Masons at China Business Law Awards 2022

Multinational law firm Pinsent Masons has won in seven categories at China Business Law Journal's annual awards.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts